Investor Alert

London Markets Close in:

Market Pulse Archives

Nov. 1, 2021, 6:29 a.m. EDT

Novavax stock jumps after submission of data on COVID-19 vaccine candidate to Health Canada, EMA completed

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Novavax Inc. (NVAX)
  • X
    iShares Biotechnology ETF (IBB)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.11% shot up 6.8% in premarket trading Monday, after the biotechnology company said it has completed its rolling submission to Canada's health authorities, Health Canada, for the authorization of its COVID-19 vaccine candidate. The company said it has also completed the submission of all data to the European Medicines Agency (EMA) for regulatory review. The company said the final step for applying for EMA authorization is an invitation from EMA to file for Conditional Marketing Authorization. "Novavax continues to deliver regulatory filings that we expect will bring the first protein-based COVID-19 vaccine based on Phase 3 data to the world," said Novavax Chief Executive Stanley Erck. "We thank the Government of Canada and the European Commission for their ongoing partnership and confidence in our COVID-19 vaccine program." The stock has tumbled 17.0% over the past three months through Friday, while the iShares Biotechnology ETF /zigman2/quotes/206189322/composite IBB -1.28% has slipped 3.7% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.84% has gained 4.8%.

US : U.S.: Nasdaq
$ 10.66
-0.23 -2.11%
Volume: 1.37M
Feb. 8, 2023 11:14a
P/E Ratio
Dividend Yield
Market Cap
$942.69 million
Rev. per Employee
US : U.S.: Nasdaq
$ 134.57
-1.75 -1.28%
Volume: 458,408
Feb. 8, 2023 11:15a
-34.99 -0.84%
Volume: 0.00
Feb. 8, 2023 11:15a

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.